Building the next era of healthcare and industry with cell data.
ACCESS
Lab. 301, 3F, TIRI, 2-4-10, Aomi, Koto-ku,
Tokyo 135-0064, JAPAN
3 minutes walk from Yurikamome "Telecom Center" station
15 minutes walk from Rinkai line "Tokyo Teleport" station
Digital Cytology
Cytology has long contributed to reducing cancer mortality, for example in cervical cancer screening. However, it requires manual microscopy of a large number of slides, posing workforce and quality-control challenges.
With CYBO Scan, we collect large-scale, high-resolution 3D cellular images and advance AI methods built on these data. We are driving the real-world deployment of these technologies to improve the quality of early cancer screening, including cervical screening.
AI cytology
Although cytology is minimally invasive and widely used in cancer screening, the 3D structure of specimens has made digitization difficult, limiting telepathology and AI adoption.
We established technology to accurately digitize cytology specimens and productized it as CYBO Scan and CYBO View. This enables remote consultation and conferencing, and facilitates AI applications.
Platelet activation assay
If platelet activation in blood can be measured reliably, it may serve as an early biomarker for atherothrombotic diseases such as stroke and myocardial infarction. However, technical barriers have hindered practical adoption.
We are tackling this challenge by combining high-speed imaging with AI. Once established, the technology could help identify at-risk populations earlier and support timely intervention, contributing to preventive healthcare.
Projects
Quality Policy
We provide products and services to help customers learn more about cells and utilize them more widely. We have established the following items as our quality policy and work to achieve them.
We identify true needs through in-depth communication with customers, and propose and provide products that exceed customer expectations.
We will not be satisfied with the status quo, but will continue to pursue the improvement of the quality of all business processes, which will lead to customer satisfaction and improvement in the quality of our products and services.
In order to realize the quality policy, each department will set quality targets and systematically work on quality management to achieve the targets.
We comply with laws and regulations and provide products and services that customers can use without concerns.
Business Description
Manufacturing and sales of scientific instruments
Development and sales of software for research
Manufacturing and sales of reagents and consumables
Planning, development, design, manufacturing and sales of medical devices
Maintenance services related to the above items
Joint research related to cell measurement and measurement instruments
Commissioned research and development
Implementation, use, licensing, maintenance and management of intellectual property rights
All business incidental or related to the above items
Licenses
Class II Medical Device Manufacturing and Sales License (Japan)
Medical Device Manufacturing License (Japan)
Company Name
K.K. CYBO
Location
Lab. 301, 3F, TIRI, 2-4-10, Aomi, Koto-ku
Tokyo 135-0064, JAPAN
Establishment
July, 2018
Board members
Nao Nitta
Keisuke Goda
Toru Katsumoto
Yusuke Murata
Noriyuki Homma
Company Profile
Humanity has long harnessed the power of cells—the fundamental units of life—across domains such as food, healthcare, energy, and the environment. If we can further unlock this potential, we can make the world even better.
We fully leverage advanced technologies, including high-speed imaging and AI, to “measure cells properly,” enabling smarter use of cellular information. We are bringing these technologies into clinical practice, starting with testing and diagnosis—reducing the burden on healthcare professionals, improving diagnostic accuracy, and ultimately raising the quality of care.
In parallel, we are building a large-scale data foundation—a “dictionary of cells”—by precisely measuring diverse cell populations. Our goal is to create a platform that advances not only medicine but also basic research and fields such as environment and energy. By applying technology and ingenuity to illuminate cells—the foundation of life—we strive to help build a better society.